pillbase.ru

TOLVAPTAN

Active substance: tolvaptan

TABLET · TOLVAPTAN 30 mg/1

United StatesActive

Marketing holder: Novadoz Pharmaceuticals LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 3
  • Jinarc
    tolvaptan
    EMEA/H/C/002788
    Otsuka Pharmaceutical Netherlands B.V.
  • Samsca
    tolvaptan
    EMEA/H/C/000980
    Otsuka Pharmaceutical Netherlands B.V.
  • Tolvaptan Accord
    tolvaptan
    EMEA/H/C/005961
    Accord Healthcare S.L.U.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-2af0-7de4-b09b-dfd05bf74857,01a1208c-7f43-708f-8d33-fa90f50db9a7,01a1208c-83ec-78da-9fdd-0ed61e4e1328,01a1208c-a02b-7d2c-b876-80be9988368e,01a1208c-a053-70d4-8871-a494a4b81331;count=51 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
72205-131
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 72205-131 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 72205-131 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 72205-131 · Verified 2026-10-09 · open in source